JUN 2014 ARTICLE LIST >>
PharmaTutor (June- 2014)
ISSN: 2347 - 7881
Received On: 31/03/2014; Accepted On: 05/04/2014; Published On: 01/06/2014
AUTHORS: Fiza Farheen*, Sudhir Bharadwaj
Department of Phrmaceutics, Shri Ram College of Pharmacy,
Banmore, Morena (M.P.)
fizafarheen31@gmail.com
ABSTRACT:
The objective of the study was to develop an effective formulation of mebendazole chewable tablets. Mebendazole is a benzimidazole derivative with broad spectrum anthelemthic activity and excellent tolerability. Orally it is rapidly absorbed and metabolized tohydroxy and hydroxyamino, which may be responsible for its anthelmenthic action. It is widely used in the treatment of worm infestations in both humans and animals. Mebendazole chewable tablets (200 mg) were prepared by three methods viz. non aqueous granulation, aqueous granulation and direct compression and were named as NAG, AG and DC respectively. Tablet prepared by these three methods were evaluated by different parameters such as average weight, hardness, carr’s index, tapped density, friability, disintegration, content uniformity test, in-vitro dissolution etc. All the parameters were found within the specifications. The study on the dissolution profile revealed that product ‘DC’ had faster dissolution rate while compared to remaining batches and marketed product. Assay values were within the limits of 90% to 110%.
How to cite this article: F Farheen, S Bharadwaj; Formulation and Evaluation of Chewable Tablets of Mebendazole by Different Techniques; PharmaTutor; 2014; 2(6); 183-189
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1.Kanaka Durgadevi N, Prameela Rani A, Radha Madhav B, Sai Mrudula B, Int. J. Pharm. Sci. and Bio Tech., 2010, 1, 1, 20-24.
2.Swati Jagdale, Mahesh Gattani, Dhaval Bhavsar, Bhanudas Kuchekar, Aniruddha Chabukswar.Int. J. Res. Pharm. Sci., 2010, 1, 3,282-289.
3.Kathiresan K, Vijin P, Moorthi C, Manavalan R,Research Journal of Pharmaceutical, Biological and Chemical Sciences, 2010, 1,4,763-774.
4.Horton J, Fundamental Clinical Pharmacology; 2003, 17, 205-212.
5.Budavari S, Neil MJO, Smith A, Heckelman PE and Kinneary JF. The Merck Index, an encyclopedia of chemicals, drugs and biological. 12th edition. Merck Research Laboratories, Whitehouse station; 1996. p. 1-1741.
6.Herbert L, Lachman L and Schwartz BJ. Chewable tablet Pharmaceutical dosage forms: Tablets. 2nd edition; 1989.
7.Lachman L, Lieberman HA and Kanig JL. The theory and practice of industrial pharmacy. 3rd edition; 1991. p. 293
8.Nandgude TD, Chatap VK, Bhise KS and Sharma DK. Indian Drugs 2007; 44: 271-272.
9.Indian Pharmacopoeia, the controller of publication, Ministry of Health and Welfare. 1st edition; 1996. P. 1178.
10.Subhramanyam CVS and Thimasetty J. Laboratory Manual of physical pharmaceutics. 5th edition; 2005. p. 321-325.
11.United States Pharmacopoeia, United States Pharmacopoeia convention; 1993. p. 1475.
12.Sharma YR, Elementary Organic Spectroscopy Principles and Chemical applications. S.Chand and Co., New Delhi; 2005, Volume-5, 65-133.
13.Aulton ME, Wells TI, Pharmaceutics, The Science of Dosage Form Design’ Churchill Livingstone, Vingstone, London: 1988, 168.
14.Rippe E, Swarbrick J, Encyclopedia of Pharamaceutical Technology, Marcel Dekker Inc. Newyork; 1990, 3, 149-166.
.png)
